Hidradenitis Suppurativa Prospective Observational Registry and Biospecimen Repository

Part of paid clinical trials in San Francisco, California.

Sponsor
University of California, San Francisco
Study ID
NCT04115566
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
10 Years - N/A
Healthy Volunteers
Not accepted

Study Details

Hidradenitis suppurativa (HS) is a common and debilitating skin disease that is poorly understood and understudied. As a result, little is known about disease prognosis and few effective treatments exist for this condition. This prospective observational cohort study aims to comprehensively characterize the clinical and biological features of HS. The results of this research will provide a basis for the development of an HS clinical classification system and identification of potential treatments for HS.

Key Dates

Start date
Aug 1, 2020
Status verified
Apr 2026
Primary completion
May 1, 2035
Completion
May 1, 2035

Study Design

Enrollment
3,000 participants (estimated)

Primary Outcome Measure

Primary Objective [ Time Frame: 2019-2035 ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of California San FranciscoSan FranciscoCalifornia94115
Haley B Naik, MD, MHSc, FAAD (PRINCIPAL_INVESTIGATOR)

Find similar trials in San Francisco, CA

By condition
Hidradenitis suppurativa
By specialty
DermatologyRheumatologyAutoimmune disease
By research site
University of California San Francisco· San Francisco, CA

Related Studies